Collection home page  Gynecologic Oncology 2016

RSS Feed


PreviewIssue DateTitleContributor(s)
2016 GO Volume 140 Issue 1 January (10).pdf.jpg2016Gynecologic Oncology Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancerRen, Yulan; Huang, Xiaowei; Shan, Boer; Wu, Xiaohua; Huang, Xiao; Shi, Daren; Wang, Huaying
2016 GO Volume 140 Issue 1 January (8).pdf.jpg2016Gynecologic Oncology F-FDG-PET / CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancerVallius, Tuulia; Peter, Anniina; Auranen, Annika; Carpén, Olli; Kemppainen, Jukka; Matomäki, Jaakko; Oksa, Sinikka; Roering, Pia; Seppänen, Marko; Grénman, Seija; Hynninen, Johanna
2016 GO Volume 141 Issue 1 April (5).pdf.jpg2016Gynecologic Oncology Mutation spectrum of POLE and POLD1 mutations in South East Asian women presenting with grade 3 endometrioid endometrial carcinomasWong, Adele; Hong, Chik; Loong, Wai; Tham, Jill M; Mansor, Sorsiah; Loh, Eva; Jain, Sudhanshi; Vikas, Nadkarni N; Huey, Sze; Hoai, Sock; Tzu, Shao; Hock, Sung; Hong, Wanjin; Ngeow, Joanne
2016 GO Volume 140 Issue 3 March (20).pdf.jpg2016Gynecologic Oncology Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancerJorge, Soledad; Hou, June Y; Tergas, Ana I; Burke, William M; Huang, Yongmei; Hu, Jim C; Ananth, Cande V; Neugut, Alfred I; Hershman, Dawn L; Wright, Jason D
2016 GO Volume 141 Issue 2 May (13).pdf.jpg2016Gynecologic Oncology Estrogen receptor-alpha as a predictive biomarker in endometrioid endometrial cancerBackes, Floor J; Walker, Christopher J; Goodfellow, Paul J; Hade, Erinn M; Agarwal, Garima; Mutch, David; Cohn, David E; Suarez, Adrian A
2016 GO Volume 141 Issue 1 April (19).pdf.jpg2016Gynecologic Oncology Epidemiology and outcomes of squamous ovarian carcinoma ; a population-based studyNasioudis, Dimitrios; Sisti, Giovanni; Kanninen, Tomi T; Holcomb, Kevin; Di, Mariarosaria; Fambrini, Massimiliano; Witkin, Steven S
2016 GO Volume 141 Issue 2 May (25).pdf.jpg2016Gynecologic Oncology Prognostic impact of clinical tumor size on overall survival for subclassifying stages I and II vaginal cancer : A SEER analysisWolfson, Aaron H; Reis, Isildinha M; Portelance, Lorraine; Diaz, Dayssy A; Zhao, Wei; Gibb, Randall K
2016 GO Volume 140 Issue 3 March (17).pdf.jpg2016Gynecologic Oncology First application of the Automated QUantitative Analysis ( AQUA ) technique to quantify PTEN protein expression in ovarian cancer : A correlative study of NCIC CTG OV . 16 ☆Weberpals, J I; Amin, M S; Chen, B E; Tu, D; Spaans, J N; Squire, J A; Eisenhauer, E A; Virk, S; Ma, D; Duciaume, M; Hoskins, P; Lebrun, D P
2016 GO Volume 141 Issue 1 April (11).pdf.jpg2016Gynecologic Oncology Precision medicineColeman, Robert L; Matulonis, Ursula A
2016 GO Volume 140 Issue 2 February (16).pdf.jpg2016Gynecologic Oncology Emerging strategies for targeting PI3K in gynecologic cancer ☆Bregar, Amy J; Growdon, B
2016 GO Volume 141 Issue 2 May (20).pdf.jpg2016Gynecologic Oncology Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgeryHeitz, Florian; Harter, Philipp; Alesina, Piero F; Walz, Martin K; Lorenz, Dietmar; Groeben, Harald; Heikaus, Sebastian; Fisseler-eckhoff, Anette; Schneider, Stephanie; Ataseven, Beyhan; Kurzeder, Christian; Prader, Sonia; Beutel, Bianca; Traut, Alexander
2016 GO Volume 140 Issue 1 January (21).pdf.jpg2016Gynecologic Oncology MUC20 promotes aggressive phenotypes of epithelial ovarian cancer cells via activation of the integrin β 1 pathwayChen, Chi-hau; Shyu, Ming-kwang; Wang, Shu-wei; Chou, Chih-hsing; Huang, Miao-juei; Lin, Tzu-chi; Chen, Syue-ting; Lin, Ho-hsiung; Huang, Min-chuan
2016 GO Volume 140 Issue 1 January (20).pdf.jpg2016Gynecologic Oncology Lymphopenia and its association with survival in patients with locally advanced cervical cancerWu, Emily S; Oduyebo, Titilope; Cobb, Lauren P; Cholakian, Diana; Kong, Xiangrong; Fader, Amanda N; Levinson, Kimberly L; Tanner, Edward J; Stone, Rebecca L; Piotrowski, Anna; Grossman, Stuart; Long, Kara
2016 GO Volume 140 Issue 2 February (26).pdf.jpg2016Gynecologic Oncology Phase II study of concurrent chemoradiotherapy with weekly cisplatin and paclitaxel in patients with locally advanced uterine cervical cancer : The JACCRO GY-01 trialUmayahara, Kenji; Takekuma, Munetaka; Hirashima, Yasuyuki; Noda, Shin-ei; Ohno, Tatsuya; Miyagi, Etsuko; Hirahara, Fumiki; Hirata, Eiji; Kondo, Eiji; Tabata, Tsutomu; Nagai, Yutaka; Aoki, Yoichi
2016 GO Volume 141 Issue 2 May (1).pdf.jpg2016Gynecologic Oncology No clinical utility of KRAS variant rs61764370 for ovarian or breast cancerHollestelle, Antoinette; Baan, Frederieke H Van Der; Berchuck, Andrew; Johnatty, Sharon E; Aben, Katja K; Agnarsson, Bjarni A; Alducci, Elisa; Andrulis, Irene L; Anton-culver, Hoda; Antonenkova, Natalia N; Antoniou, Antonis C; Apicella, Carmel; Arndt, Volker; Arnold,
2016 GO Volume 141 Issue 1 April (4).pdf.jpg2016Gynecologic Oncology Prediction of taxane and platinum sensitivity in ovarian cancer based on gene expression pro fi lesMurakami, Ryusuke; Matsumura, Noriomi; Brown, J B; Wang, Zhipeng; Yamaguchi, Ken; Abiko, Kaoru
2016 GO Volume 140 Issue 3 March (24).pdf.jpg2016Gynecologic Oncology Ovarian cancer outcomes : Predictors of early death ☆ , ☆☆Urban, Renata R; He, Hao; Alfonso, Raphael; Hardesty, Melissa M; Gray, Heidi J; Goff, Barbara A
2016 GO Volume 140 Issue 3 March (26).pdf.jpg2016Gynecologic Oncology Racial disparities in survival in malignant germ cell tumors of the ovaryHinchcliff, Emily; Rauh-hain, J Alejandro; Clemmer, Joel T; Diver, Elisabeth; Hall, Tracilyn; Stall, Jennifer; Clark, Rachel; Schorge, John
2016 GO Volume 140 Issue 1 January (31).pdf.jpg2016Gynecologic Oncology Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based studyEysbouts, Y K; Bulten, J; Ottevanger, P B; Thomas, C M G; Kate-booij, M J; Herwaarden, A E Van; Siebers, A G; Sweep, F C G J; Massuger, L F A G
2016 GO Volume 140 Issue 3 March (35).pdf.jpg2016Gynecologic Oncology Wilms tumor protein 1 ( WT1 ) — Not only a diagnostic but also a prognostic marker in high-grade serous ovarian carcinomaTabea, Eliane; Denkert, Carsten; Sehouli, Jalid; Alisa, Catarina; Dietel, Manfred; Braicu, Ioana; Letsch, Anne; Darb-esfahani, Silvia

Browse